Ansamycins having improved pharmacological and biological properties
Details for Australian Patent Application No. 2003217393 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): PCT/US02/39993 12.12.02 US; 60/367,055 22.03.02 US; 60/355,275 08.02.02 US
25 September 2003 Application Open to Public Inspection
Published as AU-B-2003217393
26 February 2009 Application Accepted
Published as AU-B-2003217393
25 June 2009 Standard Patent Sealed
25 June 2009 Corrigenda
Applications Accepted - Name Index Under the name Conforma Therapeutics Corporation, Application No. 2003217393, under INID (72) correct the coinventor to Le Brazidec, Jean-Yves
2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003217394-System and method for targeted advertising and marketing
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser